Karl Willert

Institution Name:

University of California, San Diego

Total Awards:

4

Award Value:

$6,453,554

Share

Awards as PI

Program Type	Institution	Grant Title	Award Value
Basic Biology I	University of California, San Diego	WNT signaling and the control of cell fate decisions in human pluripotent stem cells.	$1,329,298
Shared Labs	University of California, San Diego	Enhancing Facilities for Genetic Manipulation and Engineering of Human Embryonic Stem Cells at UCSD	$1,737,133
Tools and Technologies II	University of California, San Diego	Homologous recombination in human pluripotent stem cells using adeno-associated virus.	$1,659,043
Shared Labs	University of California, San Diego	Enhancing Facilities for Genetic Manipulation and Engineering of Human Embryonic Stem Cells at UCSD	$1,728,080
			Total: $6,453,554.00

Publications

Genes Dev 2012 Wnt signaling: the beta-cat(enin)'s meow. (PubMed: 22279043)
Nat Protoc 2012 Arrayed cellular microenvironments for identifying culture and differentiation conditions for stem, primary and rare cell populations. (PubMed: 22422316)
Cold Spring Harb Perspect Biol 2012 Wnt proteins. (PubMed: 22952392)
PLoS One 2013 Use of a molecular genetic platform technology to produce human wnt proteins reveals distinct local and distal signaling abilities. (PubMed: 23516471)
Stem Cells Dev 2009 Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technology. (PubMed: 19327010)
PLoS One 2013 Encodes Two Isoforms with Distinct Functions in Cancers. (PubMed: 24260410)
Stem Cell Reports 2013 Analysis of SOX2-Expressing Cell Populations Derived from Human Pluripotent Stem Cells. (PubMed: 24286033)
Proc Natl Acad Sci U S A 2014 The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells. (PubMed: 24474766)
Stem Cell Reports 2014 Endogenous WNT Signaling Regulates hPSC-Derived Neural Progenitor Cell Heterogeneity and Specifies Their Regional Identity. (PubMed: 25458891)
Cell Rep 2014 A Rare Human Syndrome Provides Genetic Evidence that WNT Signaling Is Required for Reprogramming of Fibroblasts to Induced Pluripotent Stem Cells. (PubMed: 25464842)